COVIDIEN MANUFACTURING GRENOBLE
Covidien Manufacturing Grenoble is a French société par actions simplifiée (SAS) registered under SIREN 331 407 742 (SIRET 331 407 742 00013), with its registered office at 16 Avenue Charles de Gaulle, 38800 Le Pont-de-Claix, in the Isère department near Grenoble. The company was created on 1 October 1984 and is currently listed as active on the French national business register; an active registration status confirms only that no closure procedure has been recorded and is not evidence of current trading activity.
Under the French activity classification (code NAF/APE 32.50A), Covidien Manufacturing Grenoble’s principal registered activity is the manufacture of medical, surgical and dental equipment. The Le Pont-de-Claix site has a long history as a surgical-device manufacturing plant, and available registry data place its workforce in the 200-249 employee band as of 2023, a company-level figure rather than a group-wide total.
Covidien Manufacturing Grenoble has been registered under several names since incorporation, including Sherwood-Davis & Geck Needles, Société des Sutures Renodex SA and Tyco Healthcare Manufacturing France, before being renamed Tyco Healthcare Grenoble and then Covidien Manufacturing Grenoble in 2009, in line with the Covidien plc rebrand that followed Tyco International’s 2007 healthcare spin-off. Medtronic plc completed its acquisition of Covidien plc on 26 January 2015. Covidien Manufacturing Grenoble has continued to be identified as a Medtronic plc subsidiary in Medtronic’s U.S. Securities and Exchange Commission filings from fiscal 2015 through fiscal 2026, and its registered French name has not been changed to reflect that acquisition as of this profile’s retrieval date. The gd_website on file (covidien.com) corresponds to the retired Covidien corporate brand rather than a current, entity-specific website.
- Company fundamentals
- Corporate linkage & group structures
- Digitized company financials
- Firmographics — websites, social profiles, revenue and employee estimates
Shareholders
1
Shareholders of Covidien Manufacturing Grenoble
The shareholder record on file for Covidien Manufacturing Grenoble (SIREN 331 407 742), sourced from INPI via the Global Database registry feed and verified 10 August 2026, lists a single shareholder: Thierry Grivaud, an individual, holding ordinary shares. No shareholding percentage, share quantity or total holding value is disclosed in that source, and the recorded share value is a nominal reference figure rather than a market valuation. Thierry Grivaud is also named in French registry filings as the company’s current Directeur Général (managing director), appointed 12 October 2023; whether the recorded shareholding reflects a nominal or qualifying holding rather than a substantive economic interest has not been independently confirmed. No corporate or institutional shareholder is disclosed in any source reviewed for this profile, notwithstanding Covidien Manufacturing Grenoble’s continued listing as a subsidiary of Medtronic plc in that company’s SEC filings (see Group structure).
Data availability
Shareholder disclosure is Partial. French sociétés par actions simplifiées file incorporation and share-transfer notices with the registre du commerce et des sociétés, but a consolidated, current shareholder register is not published in full on the open registries reviewed, and beneficial-ownership (registre des bénéficiaires effectifs) filings were not directly accessible for this profile. No verified ultimate beneficial owner can be identified from the information available; this is not evidence that none exists.
Sources
- INPI (Institut National de la Propriété Industrielle), data.inpi.fr — shareholder record verified 10 August 2026, retrieved 11 August 2026.
- Annuaire des entreprises (French government business register API), retrieved 17 September 2026.
- societe.com company record, retrieved 17 September 2026.
| Shareholder | Type | Holding | Source Document |
|---|---|---|---|
| Thierry Grivaud | INPI (Institut National de la Propriété Industrielle) |
Officers
17
Directors and officers of Covidien Manufacturing Grenoble
Registry filings for Covidien Manufacturing Grenoble show a series of Président (President) and Directeur Général (Managing Director) appointments since at least 2016. The stored Global Database extract (verified 11 August 2026) captures 5 of a reported 20 officer records, all marked as no longer holding office, and does not include the company’s current officers. Cross-checked against Bodacc (the official French legal-announcements gazette) and the current societe.com registry record, Didier Perrin has held the role of Président since 12 October 2023 and Thierry Grivaud has held the role of Directeur Général since the same date, with no resignation recorded in the sources reviewed for either. These are legal governance roles under French SAS rules rather than disclosed personal occupations; occupation is not separately reported. Nationality is not disclosed in any source reviewed for this entity.
Recent officer changes
Sabine Rachel Dukan departed as Directeur Général effective 30 July 2023 (source: Bodacc). Didier Perrin was appointed Président effective 12 October 2023 (source: societe.com registry record). Thierry Grivaud was appointed Directeur Général effective 12 October 2023 (source: societe.com registry record).
Data availability
Officer information for this jurisdiction is Partial. Bodacc publishes dated notices of appointment, resignation and role changes that are broadly consistent with the current registry snapshot, but the stored registry extract used elsewhere in this profile is incomplete (5 of 20 records) and predates the most recent appointments. Nationality is not publicly disclosed in the French filings reviewed. One historical officer record (Thierry Pascal Marie Grivaud, Chief Executive Officer) lists a correspondence postal code in Tolochenaz, Switzerland, the location of a known Medtronic facility; this is a correspondence address only, not evidence of nationality or residence, and has not been independently verified as materially significant.
Sources
- INPI (Institut National de la Propriété Industrielle), data.inpi.fr, officer records verified 11 August 2026.
- BODACC open data (annonces-commerciales dataset), retrieved 17 September 2026.
- societe.com company record, retrieved 17 September 2026.
Registry feed — rows exactly as filed with INPI (Institut National de la Propriété Industrielle), including entries the profile above does not cover.
Group Structure
Group structure of Covidien Manufacturing Grenoble
The INPI-sourced registry extract used elsewhere in this profile (verified 11 August 2026) records no parent, subsidiary or ownership linkage for Covidien Manufacturing Grenoble. Independent verification through Medtronic plc’s U.S. Securities and Exchange Commission filings, however, confirms a corporate relationship: Covidien Manufacturing Grenoble appears in the subsidiaries exhibit (Exhibit 21.1) attached to Medtronic plc’s Form 10-K annual reports continuously from fiscal year 2015 through fiscal year 2026, consistent with Medtronic plc’s completed acquisition of Covidien plc on 26 January 2015. Medtronic plc, an Irish public limited company listed on the New York Stock Exchange (NYSE: MDT), is accordingly the verified ultimate parent. Exhibit 21.1 does not itemise an ownership percentage or identify the immediate holding entity between Medtronic plc and this French entity. French filing sources reviewed for this profile repeatedly reference a separately registered company, Medtronic Holdings France (SIREN 543 780 068), in connection with Covidien Manufacturing Grenoble between 1999 and 2019, but no source confirms a specific shareholding or ownership percentage by that entity; this is treated as a possible relationship (unverified) rather than a confirmed immediate parent.
Verified corporate relationships
| Entity | Country | Registration number | Relationship | Ownership | Status | Information date |
|---|---|---|---|---|---|---|
| Medtronic plc | Ireland (NYSE-listed) | SEC CIK 0001613103 | Ultimate parent (subsidiary listed in parent’s SEC filing) | Ownership percentage not disclosed | Confirmed (10-K Exhibit 21.1, FY2015–FY2026) | 2026-09-17 |
Recent structural changes
Medtronic plc completed its acquisition of Covidien plc, the group to which Covidien Manufacturing Grenoble then belonged, on 26 January 2015. Covidien Manufacturing Grenoble has been listed as a Medtronic plc subsidiary in every Medtronic 10-K Exhibit 21.1 filing reviewed from fiscal 2015 to fiscal 2026, and its registered French name has not changed since 2009.
Data availability
Corporate-linkage information for this entity is Partial. The French registry source used elsewhere in this profile discloses no group data, while the ultimate parent’s U.S. securities filings confirm a subsidiary relationship without disclosing the ownership percentage or the immediate holding structure. The possible role of Medtronic Holdings France (SIREN 543 780 068) as an intermediate holding company is unverified.
Sources
- INPI (Institut National de la Propriété Industrielle), data.inpi.fr, verified 11 August 2026.
- Medtronic plc SEC EDGAR filing history (Form 10-K, Exhibit 21.1, FY2015–FY2026), retrieved 17 September 2026.
- BODACC open data, retrieved 17 September 2026.
- societe.com company record, retrieved 17 September 2026.
Get complete shareholder and officer records, ultimate beneficial owner resolution, and ongoing ownership monitoring.
Frequently Asked Questions
What is the legal name and registration number of Covidien Manufacturing Grenoble?
The legal name is Covidien Manufacturing Grenoble, registered in France under SIREN 331 407 742 (SIRET 331 407 742 00013).
What is Covidien Manufacturing Grenoble's current registration status?
The company is listed as active on the French national business register as of the most recent retrieval (17 September 2026). Active status reflects registration only and is not confirmation of ongoing trading activity.
When was Covidien Manufacturing Grenoble incorporated?
It was created on 1 October 1984, per both the Global Database registry extract and the official French government business-register API.
What is Covidien Manufacturing Grenoble's legal form?
French registry sources (societe.com, citing INPI/RCS data) describe it as a société par actions simplifiée (SAS), a private simplified joint-stock company.
Where is Covidien Manufacturing Grenoble located?
Its registered office is at 16 Avenue Charles de Gaulle, 38800 Le Pont-de-Claix, in the Isère department near Grenoble, France.
What does Covidien Manufacturing Grenoble do?
Under French activity code NAF 32.50A, its principal registered activity is the manufacture of medical, surgical and dental equipment, continuing a long history as a surgical-device manufacturing site.
Has Covidien Manufacturing Grenoble changed its name?
Yes. Registry history shows earlier names including Sherwood-Davis & Geck Needles, Société des Sutures Renodex SA and Tyco Healthcare Manufacturing France, before it was renamed Tyco Healthcare Grenoble and then Covidien Manufacturing Grenoble in 2009.
Was Covidien Manufacturing Grenoble affected by the Medtronic acquisition of Covidien?
Yes. Medtronic plc completed its acquisition of Covidien plc on 26 January 2015. Covidien Manufacturing Grenoble has continued to appear as a Medtronic plc subsidiary in Medtronic's SEC 10-K Exhibit 21.1 filings from fiscal 2015 through fiscal 2026, and this French entity's registered name has not been changed to reflect Medtronic ownership as of the retrieval date.
Who owns Covidien Manufacturing Grenoble?
One individual shareholder, Thierry Grivaud, is on file with no disclosed percentage. Separately, Medtronic plc's SEC filings list the company as a subsidiary, though the immediate holding structure and ownership percentage are not disclosed in the sources reviewed.
Who are the current officers of Covidien Manufacturing Grenoble?
Per registry filings verified against societe.com and Bodacc, Didier Perrin has held the role of Président and Thierry Grivaud the role of Directeur Général, both since 12 October 2023.
Is Covidien Manufacturing Grenoble part of a corporate group?
Yes. Medtronic plc's own SEC Exhibit 21.1 filings confirm it as a subsidiary, though no source reviewed discloses a verified ownership percentage or the immediate parent in the chain.
What is Covidien Manufacturing Grenoble's employee count?
French government data places its workforce in the 200-249 employee band (INSEE size tranche 31) as of 2023, a company-level figure.
Is Covidien Manufacturing Grenoble a publicly listed company?
No. It is a private French SAS and is not itself listed on any stock exchange. Its former ultimate parent, Covidien plc, was listed on the NYSE until its 2015 acquisition by Medtronic plc, which remains NYSE-listed under the ticker MDT.
What sources were used to verify Covidien Manufacturing Grenoble's registry data?
INPI (data.inpi.fr), the French government Annuaire des entreprises API, Bodacc open data, societe.com, and Medtronic plc SEC EDGAR filings.
Does Covidien Manufacturing Grenoble have its own subsidiaries?
Not found. No source reviewed for this profile identifies any direct or indirect subsidiaries of Covidien Manufacturing Grenoble itself.